4-Methylephedrine
| Clinical data | |
|---|---|
| Pronunciation | /ˌfɔːr mɛθəlɪˈfɛdrɪn/ |
| Other names | 4-ME; Dihydromephedrone; DHMMC; β-Hydroxy-4-methylmethamphetamine; 4-Methyl-β-hydroxymethamphetamine |
| Drug class | Stimulant; Monoamine releasing agent |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C11H17NO |
| Molar mass | 179.263 g·mol−1 |
| 3D model (JSmol) | |
| Density | 0.987 to 1.00 g/cm3 |
| Melting point | 56.1 to 89.0 °C (133.0 to 192.2 °F) |
| Boiling point | 269 to 281 °C (516 to 538 °F) |
| Solubility in water | 1.61e-2 to 0.110 (water) mg/mL (20 °C) |
| |
| |
4-Methylephedrine (4-ME), also known as dihydromephedrone (DHMMC) or as β-hydroxy-4-methylmethamphetamine, is a putative stimulant drug of the phenethylamine, amphetamine, and β-hydroxyamphetamine families. It is the β-hydroxy analogue of mephedrone and is a known metabolite of mephedrone. The drug acts as a monoamine reuptake inhibitor and monoamine releasing agent, albeit with relatively low potency and far less than that of mephedrone.
Category:
- Drugs not assigned an ATC code